WEBVTT
Kind: captions
Language: en

00:00:00.179 --> 00:00:02.540
 
this program is brought to you by Emory

00:00:02.540 --> 00:00:02.550
this program is brought to you by Emory
 

00:00:02.550 --> 00:00:04.999
this program is brought to you by Emory
University

00:00:04.999 --> 00:00:05.009
University
 

00:00:05.009 --> 00:00:07.290
University
everybody who had antibiotic to the

00:00:07.290 --> 00:00:07.300
everybody who had antibiotic to the
 

00:00:07.300 --> 00:00:09.140
everybody who had antibiotic to the
virus was still infected with the virus

00:00:09.140 --> 00:00:09.150
virus was still infected with the virus
 

00:00:09.150 --> 00:00:12.379
virus was still infected with the virus
so unfortunately unlike most viruses

00:00:12.379 --> 00:00:12.389
so unfortunately unlike most viruses
 

00:00:12.389 --> 00:00:15.119
so unfortunately unlike most viruses
exposure and infection meant lifelong

00:00:15.119 --> 00:00:15.129
exposure and infection meant lifelong
 

00:00:15.129 --> 00:00:17.070
exposure and infection meant lifelong
infection and then even more

00:00:17.070 --> 00:00:17.080
infection and then even more
 

00:00:17.080 --> 00:00:19.470
infection and then even more
unfortunately it was progressive so it

00:00:19.470 --> 00:00:19.480
unfortunately it was progressive so it
 

00:00:19.480 --> 00:00:21.179
unfortunately it was progressive so it
looked like everybody infected with the

00:00:21.179 --> 00:00:21.189
looked like everybody infected with the
 

00:00:21.189 --> 00:00:23.400
looked like everybody infected with the
virus would ultimately died from the

00:00:23.400 --> 00:00:23.410
virus would ultimately died from the
 

00:00:23.410 --> 00:00:25.890
virus would ultimately died from the
virus so when you did a survey of a

00:00:25.890 --> 00:00:25.900
virus so when you did a survey of a
 

00:00:25.900 --> 00:00:27.739
virus so when you did a survey of a
hundred people and twenty people had it

00:00:27.739 --> 00:00:27.749
hundred people and twenty people had it
 

00:00:27.749 --> 00:00:29.970
hundred people and twenty people had it
for most of us that meant that twenty

00:00:29.970 --> 00:00:29.980
for most of us that meant that twenty
 

00:00:29.980 --> 00:00:32.190
for most of us that meant that twenty
people would die unless treatments and

00:00:32.190 --> 00:00:32.200
people would die unless treatments and
 

00:00:32.200 --> 00:00:34.729
people would die unless treatments and
better care could be made available

00:00:34.729 --> 00:00:34.739
better care could be made available
 

00:00:34.739 --> 00:00:36.810
better care could be made available
prevention recommendations came out

00:00:36.810 --> 00:00:36.820
prevention recommendations came out
 

00:00:36.820 --> 00:00:39.120
prevention recommendations came out
before the virus was discovered and they

00:00:39.120 --> 00:00:39.130
before the virus was discovered and they
 

00:00:39.130 --> 00:00:41.100
before the virus was discovered and they
were pretty cogent they helped us avoid

00:00:41.100 --> 00:00:41.110
were pretty cogent they helped us avoid
 

00:00:41.110 --> 00:00:42.900
were pretty cogent they helped us avoid
transmission to healthcare and

00:00:42.900 --> 00:00:42.910
transmission to healthcare and
 

00:00:42.910 --> 00:00:44.490
transmission to healthcare and
laboratory workers by following

00:00:44.490 --> 00:00:44.500
laboratory workers by following
 

00:00:44.500 --> 00:00:47.640
laboratory workers by following
hepatitis B precautions avoid sexual

00:00:47.640 --> 00:00:47.650
hepatitis B precautions avoid sexual
 

00:00:47.650 --> 00:00:49.080
hepatitis B precautions avoid sexual
contact with people who might be

00:00:49.080 --> 00:00:49.090
contact with people who might be
 

00:00:49.090 --> 00:00:53.100
contact with people who might be
affected or at high risk and avoid

00:00:53.100 --> 00:00:53.110
affected or at high risk and avoid
 

00:00:53.110 --> 00:00:55.410
affected or at high risk and avoid
donating blood if we're in a group that

00:00:55.410 --> 00:00:55.420
donating blood if we're in a group that
 

00:00:55.420 --> 00:00:57.690
donating blood if we're in a group that
was at high risk for AIDS these

00:00:57.690 --> 00:00:57.700
was at high risk for AIDS these
 

00:00:57.700 --> 00:00:59.190
was at high risk for AIDS these
recommendations still make a lot of

00:00:59.190 --> 00:00:59.200
recommendations still make a lot of
 

00:00:59.200 --> 00:01:01.650
recommendations still make a lot of
sense after the virus was discovered in

00:01:01.650 --> 00:01:01.660
sense after the virus was discovered in
 

00:01:01.660 --> 00:01:04.740
sense after the virus was discovered in
a 1987 AZT was discovered it's a drug

00:01:04.740 --> 00:01:04.750
a 1987 AZT was discovered it's a drug
 

00:01:04.750 --> 00:01:07.230
a 1987 AZT was discovered it's a drug
that was too toxic for cancer discovered

00:01:07.230 --> 00:01:07.240
that was too toxic for cancer discovered
 

00:01:07.240 --> 00:01:09.539
that was too toxic for cancer discovered
by a man named Jerome Horowitz in

00:01:09.539 --> 00:01:09.549
by a man named Jerome Horowitz in
 

00:01:09.549 --> 00:01:11.520
by a man named Jerome Horowitz in
Michigan Michigan Cancer Foundation in

00:01:11.520 --> 00:01:11.530
Michigan Michigan Cancer Foundation in
 

00:01:11.530 --> 00:01:14.520
Michigan Michigan Cancer Foundation in
1970 and it was to can't too toxic for

00:01:14.520 --> 00:01:14.530
1970 and it was to can't too toxic for
 

00:01:14.530 --> 00:01:17.160
1970 and it was to can't too toxic for
cancer patients that they tried on

00:01:17.160 --> 00:01:17.170
cancer patients that they tried on
 

00:01:17.170 --> 00:01:18.709
cancer patients that they tried on
parent must not work very well either

00:01:18.709 --> 00:01:18.719
parent must not work very well either
 

00:01:18.719 --> 00:01:21.419
parent must not work very well either
and so they put it on the shelf and

00:01:21.419 --> 00:01:21.429
and so they put it on the shelf and
 

00:01:21.429 --> 00:01:23.429
and so they put it on the shelf and
Burroughs Wellcome bought it and was

00:01:23.429 --> 00:01:23.439
Burroughs Wellcome bought it and was
 

00:01:23.439 --> 00:01:25.919
Burroughs Wellcome bought it and was
sitting on the shelf until Bobby our

00:01:25.919 --> 00:01:25.929
sitting on the shelf until Bobby our
 

00:01:25.929 --> 00:01:27.779
sitting on the shelf until Bobby our
Chauhan and Sam Broder at the National

00:01:27.779 --> 00:01:27.789
Chauhan and Sam Broder at the National
 

00:01:27.789 --> 00:01:29.160
Chauhan and Sam Broder at the National
Cancer Institute found that it was

00:01:29.160 --> 00:01:29.170
Cancer Institute found that it was
 

00:01:29.170 --> 00:01:32.489
Cancer Institute found that it was
effective in vitro against HIV and then

00:01:32.489 --> 00:01:32.499
effective in vitro against HIV and then
 

00:01:32.499 --> 00:01:34.709
effective in vitro against HIV and then
was soon tried in trial and it was a

00:01:34.709 --> 00:01:34.719
was soon tried in trial and it was a
 

00:01:34.719 --> 00:01:36.330
was soon tried in trial and it was a
proof-of-concept at an antiretroviral

00:01:36.330 --> 00:01:36.340
proof-of-concept at an antiretroviral
 

00:01:36.340 --> 00:01:41.129
proof-of-concept at an antiretroviral
drug would work at that time doctors and

00:01:41.129 --> 00:01:41.139
drug would work at that time doctors and
 

00:01:41.139 --> 00:01:42.779
drug would work at that time doctors and
infectious disease doctors were very

00:01:42.779 --> 00:01:42.789
infectious disease doctors were very
 

00:01:42.789 --> 00:01:45.599
infectious disease doctors were very
skeptical of antivirals in general there

00:01:45.599 --> 00:01:45.609
skeptical of antivirals in general there
 

00:01:45.609 --> 00:01:47.010
skeptical of antivirals in general there
were only a couple that had marginal

00:01:47.010 --> 00:01:47.020
were only a couple that had marginal
 

00:01:47.020 --> 00:01:50.039
were only a couple that had marginal
efficacy and people thought there's

00:01:50.039 --> 00:01:50.049
efficacy and people thought there's
 

00:01:50.049 --> 00:01:51.270
efficacy and people thought there's
never going to be anything it's going to

00:01:51.270 --> 00:01:51.280
never going to be anything it's going to
 

00:01:51.280 --> 00:01:52.289
never going to be anything it's going to
work against something that's

00:01:52.289 --> 00:01:52.299
work against something that's
 

00:01:52.299 --> 00:01:55.230
work against something that's
complicated as aids and AZT didn't work

00:01:55.230 --> 00:01:55.240
complicated as aids and AZT didn't work
 

00:01:55.240 --> 00:01:58.889
complicated as aids and AZT didn't work
very well however there were courageous

00:01:58.889 --> 00:01:58.899
very well however there were courageous
 

00:01:58.899 --> 00:02:02.849
very well however there were courageous
trial that ended in 1993 called the 076

00:02:02.849 --> 00:02:02.859
trial that ended in 1993 called the 076
 

00:02:02.859 --> 00:02:04.830
trial that ended in 1993 called the 076
trial which was a trial that

00:02:04.830 --> 00:02:04.840
trial which was a trial that
 

00:02:04.840 --> 00:02:07.139
trial which was a trial that
demonstrated giving AZT to pregnant

00:02:07.139 --> 00:02:07.149
demonstrated giving AZT to pregnant
 

00:02:07.149 --> 00:02:10.080
demonstrated giving AZT to pregnant
women before delivery during delivery

00:02:10.080 --> 00:02:10.090
women before delivery during delivery
 

00:02:10.090 --> 00:02:12.660
women before delivery during delivery
into the baby afterwards greatly reduced

00:02:12.660 --> 00:02:12.670
into the baby afterwards greatly reduced
 

00:02:12.670 --> 00:02:15.149
into the baby afterwards greatly reduced
the transmission to babies again many

00:02:15.149 --> 00:02:15.159
the transmission to babies again many
 

00:02:15.159 --> 00:02:17.160
the transmission to babies again many
skeptics including some here in Atlanta

00:02:17.160 --> 00:02:17.170
skeptics including some here in Atlanta
 

00:02:17.170 --> 00:02:18.660
skeptics including some here in Atlanta
about that trial

00:02:18.660 --> 00:02:18.670
about that trial
 

00:02:18.670 --> 00:02:20.670
about that trial
but it really worked and was an

00:02:20.670 --> 00:02:20.680
but it really worked and was an
 

00:02:20.680 --> 00:02:22.410
but it really worked and was an
important proof of concept that really

00:02:22.410 --> 00:02:22.420
important proof of concept that really
 

00:02:22.420 --> 00:02:24.809
important proof of concept that really
revolutionized their ability to prevent

00:02:24.809 --> 00:02:24.819
revolutionized their ability to prevent
 

00:02:24.819 --> 00:02:27.330
revolutionized their ability to prevent
transmission to newborns and finally in

00:02:27.330 --> 00:02:27.340
transmission to newborns and finally in
 

00:02:27.340 --> 00:02:29.750
transmission to newborns and finally in
1995 highly active antiretroviral

00:02:29.750 --> 00:02:29.760
1995 highly active antiretroviral
 

00:02:29.760 --> 00:02:33.120
1995 highly active antiretroviral
therapy or heart became demonstrated to

00:02:33.120 --> 00:02:33.130
therapy or heart became demonstrated to
 

00:02:33.130 --> 00:02:34.949
therapy or heart became demonstrated to
really alter the course of the epidemic

00:02:34.949 --> 00:02:34.959
really alter the course of the epidemic
 

00:02:34.959 --> 00:02:36.600
really alter the course of the epidemic
for millions of people throughout the

00:02:36.600 --> 00:02:36.610
for millions of people throughout the
 

00:02:36.610 --> 00:02:39.390
for millions of people throughout the
world at first really just a developed

00:02:39.390 --> 00:02:39.400
world at first really just a developed
 

00:02:39.400 --> 00:02:43.260
world at first really just a developed
world it was never going to be available

00:02:43.260 --> 00:02:43.270
world it was never going to be available
 

00:02:43.270 --> 00:02:44.460
world it was never going to be available
to people in developing countries

00:02:44.460 --> 00:02:44.470
to people in developing countries
 

00:02:44.470 --> 00:02:48.000
to people in developing countries
because it would be too expensive but

00:02:48.000 --> 00:02:48.010
because it would be too expensive but
 

00:02:48.010 --> 00:02:50.309
because it would be too expensive but
due to a lot of forces including the

00:02:50.309 --> 00:02:50.319
due to a lot of forces including the
 

00:02:50.319 --> 00:02:52.860
due to a lot of forces including the
lobbying of many many doctors in the

00:02:52.860 --> 00:02:52.870
lobbying of many many doctors in the
 

00:02:52.870 --> 00:02:55.080
lobbying of many many doctors in the
developed world and activists the prices

00:02:55.080 --> 00:02:55.090
developed world and activists the prices
 

00:02:55.090 --> 00:02:56.850
developed world and activists the prices
went down and now there are five million

00:02:56.850 --> 00:02:56.860
went down and now there are five million
 

00:02:56.860 --> 00:02:58.979
went down and now there are five million
people perhaps on antiretrovirals

00:02:58.979 --> 00:02:58.989
people perhaps on antiretrovirals
 

00:02:58.989 --> 00:03:01.770
people perhaps on antiretrovirals
throughout the world still far too few

00:03:01.770 --> 00:03:01.780
throughout the world still far too few
 

00:03:01.780 --> 00:03:04.830
throughout the world still far too few
but far more than anybody could have

00:03:04.830 --> 00:03:04.840
but far more than anybody could have
 

00:03:04.840 --> 00:03:06.900
but far more than anybody could have
predicted now there's going to be many

00:03:06.900 --> 00:03:06.910
predicted now there's going to be many
 

00:03:06.910 --> 00:03:10.050
predicted now there's going to be many
continuing breakthroughs we don't know

00:03:10.050 --> 00:03:10.060
continuing breakthroughs we don't know
 

00:03:10.060 --> 00:03:12.630
continuing breakthroughs we don't know
of any magical breakthroughs coming

00:03:12.630 --> 00:03:12.640
of any magical breakthroughs coming
 

00:03:12.640 --> 00:03:17.009
of any magical breakthroughs coming
through in the next week or year or two

00:03:17.009 --> 00:03:17.019
through in the next week or year or two
 

00:03:17.019 --> 00:03:19.440
through in the next week or year or two
years but there'll be many continuing

00:03:19.440 --> 00:03:19.450
years but there'll be many continuing
 

00:03:19.450 --> 00:03:21.690
years but there'll be many continuing
biologic breakthroughs and behavioural

00:03:21.690 --> 00:03:21.700
biologic breakthroughs and behavioural
 

00:03:21.700 --> 00:03:24.150
biologic breakthroughs and behavioural
breakthroughs they include post-exposure

00:03:24.150 --> 00:03:24.160
breakthroughs they include post-exposure
 

00:03:24.160 --> 00:03:27.240
breakthroughs they include post-exposure
prophylaxis prep the 05 to trial you

00:03:27.240 --> 00:03:27.250
prophylaxis prep the 05 to trial you
 

00:03:27.250 --> 00:03:30.569
prophylaxis prep the 05 to trial you
heard about today even tightly more

00:03:30.569 --> 00:03:30.579
heard about today even tightly more
 

00:03:30.579 --> 00:03:33.660
heard about today even tightly more
tightly linking therapy with HIV to

00:03:33.660 --> 00:03:33.670
tightly linking therapy with HIV to
 

00:03:33.670 --> 00:03:36.479
tightly linking therapy with HIV to
prevention or transmission with HIV none

00:03:36.479 --> 00:03:36.489
prevention or transmission with HIV none
 

00:03:36.489 --> 00:03:38.819
prevention or transmission with HIV none
of these things taken individually are

00:03:38.819 --> 00:03:38.829
of these things taken individually are
 

00:03:38.829 --> 00:03:40.069
of these things taken individually are
going to change the course of the

00:03:40.069 --> 00:03:40.079
going to change the course of the
 

00:03:40.079 --> 00:03:43.199
going to change the course of the
epidemic but combined they tell us that

00:03:43.199 --> 00:03:43.209
epidemic but combined they tell us that
 

00:03:43.209 --> 00:03:45.330
epidemic but combined they tell us that
there's going to be a need for continued

00:03:45.330 --> 00:03:45.340
there's going to be a need for continued
 

00:03:45.340 --> 00:03:47.940
there's going to be a need for continued
good care linking prevention and care

00:03:47.940 --> 00:03:47.950
good care linking prevention and care
 

00:03:47.950 --> 00:03:50.699
good care linking prevention and care
and continuing commitment on many of us

00:03:50.699 --> 00:03:50.709
and continuing commitment on many of us
 

00:03:50.709 --> 00:03:52.770
and continuing commitment on many of us
and that scientific breakthroughs will

00:03:52.770 --> 00:03:52.780
and that scientific breakthroughs will
 

00:03:52.780 --> 00:03:57.780
and that scientific breakthroughs will
continue that they're not stalled the

00:03:57.780 --> 00:03:57.790
continue that they're not stalled the
 

00:03:57.790 --> 00:03:59.819
continue that they're not stalled the
preceding program is copyrighted by

00:03:59.819 --> 00:03:59.829
preceding program is copyrighted by
 

00:03:59.829 --> 00:04:03.060
preceding program is copyrighted by
Emory University

